minimally invasive treatment
Search documents
Baird Medical to Participate in the AAES 2025 Annual Meeting
Prnewswireยท 2025-05-06 12:30
Core Insights - The AAES Annual Meeting is a key event for endocrine surgeons in North America, focusing on advancements in endocrine surgery, particularly in thyroid diseases, parathyroid, adrenal glands, and endocrine pancreas [1] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [5] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital and Columbia University Medical Center [5] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [5] Strategic Engagement - Baird Medical's participation in the AAES 2025 meeting emphasizes the importance of its MWA technology in minimally invasive treatments for endocrine conditions, especially thyroid nodules [2] - The company views the meeting as an opportunity to gain insights into surgical advancements and clinical trends, supporting its strategic initiatives and fostering collaborations [3] - Baird Medical aims to contribute to scientific exchange and advance patient care through technological innovation at the 2025 meeting in Milwaukee [4]